Bausch Health Companies Inc. Repayments of Other Long-term Debt
Bausch Health Companies Inc. (BHC) reported Repayments of Other Long-term Debt of $12.50 million for the 9-month period ending 2010-09-30, per its 10-Q filed 2010-11-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherLongTermDebt · last filed 2010-11-05
- Bausch Health Companies Inc. repayments of other long-term debt for the quarter ending 2010-09-30 was $0.00.
- Bausch Health Companies Inc. repayments of other long-term debt for the quarter ending 2010-06-30 was $12.50M.
| Period end | Repayments of Other Long-term Debt 3 month | Repayments of Other Long-term Debt 6 month | Repayments of Other Long-term Debt 9 month |
|---|---|---|---|
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-05 | $12.50M derived: sum of 2 quarters · filed 2010-11-05 | $12.50M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $12.50M 10-Q · filed 2010-08-06 | $12.50M 10-Q · filed 2010-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |